Glaxosmithkline | GSK - Capital Ordinário

Preço das Ações
54.44
Mudança Diária
-4.68 -7.92%
Mensal
-8.13%
Anual
45.44%
Q2 Previsão
53.52




Capital Ordinário Alterar Data
AbbVie USD 1.77B 1.75B 2025-06
Amgen USD 539M 1000K 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Aurora Cannabis CAD 56.71M 134.13K 2025-12
Bausch Health Companies USD 370.53M 59K 2025-12
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Canopy Growth CAD 368.28M 35.9M 2025-12
Corcept Therapeutics USD 105.97M 842K 2025-12
Drreddys Laboratories INR 832.57M 53K 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Glaxosmithkline GBP 4.08B 49.43M 2025-12
J&J USD 2.41B 1.74M 2025-12
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.91B 10.64M 2025-12
Pacira USD 41.12M 1.85M 2025-12
Perrigo USD 137.6M 0 2025-12
Pfizer USD 5.69B 1000K 2025-09
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
Sanofi EUR 1.21B 8.25M 2026-03
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Takeda JPY 1.58B 2K 2025-12
Teva Pharmaceutical Industries USD 1.15B 0 2025-12
Zoetis USD 424.93M 16.54M 2025-12